Edition:
India

People: ACADIA Pharmaceuticals Inc (ACAD.OQ)

ACAD.OQ on NASDAQ Stock Exchange Global Select Market

56.36USD
12:06am IST
Change (% chg)

$-0.30 (-0.53%)
Prev Close
$56.66
Open
$57.25
Day's High
$57.25
Day's Low
$55.96
Volume
183,987
Avg. Vol
414,410
52-wk High
$58.67
52-wk Low
$30.02

Subbiah, Ponni 

Dr. Ponni Subbiah M.D. serves as Senior Vice President, Global Head of Medical Affairs and Chief Medical Officer of the Company. Dr. Subbiah is our Senior Vice President, Global Head of Medical Affairs and Chief Medical Officer and has been with ACADIA since Octobser 2019. She is a neurologist with more than 20 years of experience leading medical and clinical research strategies across various therapeutic areas including neurology, psychiatry, opioid addiction, pain, oncology, diabetes, urology, inflammation, respiratory, and infectious diseases. Prior to joining ACADIA, Dr. Subbiah was Chief Medical Officer for Indivior Inc., with responsibility for pharmacovigilance and medical affairs globally. During her previous tenure of over 15 years at Pfizer, Inc., she held various leadership roles in global medical affairs and led Pfizer’s Global Access program. Dr. Subbiah received her medical degree from Madras Medical College in Chennai, India and completed a residency in neurology at the Mayo Graduate School of Medicine in Rochester, MN. She completed a research/clinical fellowship in AIDS Neurology at Johns Hopkins University School of Medicine and earned a Master’s degree in Public Health from the Johns Hopkins Bloomberg School of Public Health in Baltimore, MD.

Basic Compensation

Total Annual Compensation, --
Restricted Stock Award, --
Long-Term Incentive Plans, --
All Other, --
Fiscal Year Total, --

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --
Name Fiscal Year Total

Stephen Biggar

319,959

Srdjan Stankovic

5,088,270

Stephen Davis

7,631,250

Elena Ridloff

1,990,870

Austin Kim

1,906,130

Gudarz Davar

--
As Of  31 Dec 2019